Sign inJoin waitlistJoin the waitlist

EL

Erin Larkins

Hematology & Oncology

Credentials: · ·

History

Hematology and Medical Oncology
2001–2004
Internal Medicine
National Capital Consortium
2000–2001
F. Edward Hébert School of Medicine
1996–2000

Research

Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies
Clinical Cancer Research · 2007 · 110 citations
FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC
Clinical Cancer Research · 2022 · 69 citations
FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
The Oncologist · 2018 · 57 citations

RP
Richard Pazdur
20 papers
PK
Paul Kluetz
9 papers
GB
Gideon Blumenthal
8 papers
PK
Patricia Keegan
7 papers
LP
Lee Pai-Scherf
4 papers
MT
Marc Theoret
4 papers
ND
Nicole Drezner
4 papers
Shivaani Kummar
4 papers
AB
Amy Barone
3 papers
JB
Julia Beaver
3 papers
MD
Martha Donoghue
3 papers
OA
Oladimeji Akinboro
3 papers